Cresols
Medchemexpress LLC N-(p-Coumaroyl) Serotonin | 68573-24-0 | 99.0% | 1 ML
N-(p-Coumaroyl) Serotonin is a selective inhibitor of PDGFRβ, ERK1/2, and caspase-8, possessing antioxidant, anti-atherosclerotic, and anti-inflammatory properties. This compound inhibits glioblastoma cells and has the potential to improve atherosclerosis and aortic wall enlargement. It is for research use only.
- Selective inhibitor of PDGFRβ, ERK1/2, and caspase-8
- Possesses antioxidant, anti-atherosclerotic, and anti-inflammatory properties
- Inhibits glioblastoma cells (U251MG, T98G) with IC50 values ranging from 48-81 μM
- Works by inhibiting PDGF signaling, blocking Ca2+ influx, and inducing apoptosis
- Potential to improve atherosclerosis and aortic wall enlargement
- Useful in glioblastoma research
Cayman Chemical p-Cresol GlucuronIde 1mg
A metabolite of p-cresol; formed from p-cresol primarily by UGT1A6, but also by UGT1A9, in human liver and kidney microsomes; accumulates in feces, blood, and urine of patients with CKD
Medchemexpress LLC N-(p-Coumaroyl) Serotonin | 68573-24-0 | 99.0% | 10 MG
N-(p-Coumaroyl) Serotonin is a selective inhibitor of PDGFRβ, ERK1/2, and caspase-8, exhibiting antioxidant, anti-atherosclerotic, and anti-inflammatory properties. It inhibits glioblastoma cells and can improve atherosclerosis and aortic wall enlargement.
- Selective inhibitor of PDGFRβ, ERK1/2, and caspase-8
- Exhibits antioxidant, anti-atherosclerotic, and anti-inflammatory properties
- Inhibits glioblastoma cells
- Blocks calcium influx
- Induces apoptosis by activating caspase-8
- Can improve atherosclerosis and aortic wall enlargement
- Used in glioblastoma research
Cayman Chemical p-Cresol sulfatepotasIM100mg
A sulfate conjugate of p-cresol; increases migration and proliferation of isolated rat aortic VSMCs at 500 µM; increases aortic atherosclerotic plaques lesion area in nephrectomized ApoE-/- mice fed a high-fat diet when administered at 100 mg/kg per day via the drinking water; serum levels are increased in patients with advanced stage chronic kidney disease and positively associated with vascular calcification
Medchemexpress LLC 5-fluorouridine 5'-phosphate | 796-66-7 | 98.6% | 342.17 g/mol | C9H12FN2O9P | 10mg
5-Fluorouridine 5 -phosphate is an ODCase (orotidine-5 -monophosphate decarboxylase) inhibitor with a Ki value of 98 M for human ODCase and a Ki value of 645 M for Methanobacterium ODCase 5-Fluorouridine 5 -phosphate exhibits inhibitory activity against leukemia and lymphoma cell lines and can be used in cancer research [1]
Medchemexpress LLC p-Hydroxybenzaldehyde-d4 | 284474-52-8 | MFCD00190461 | 99.7% | 126.15 | C7H2D4O2 | 25mg
p-Hydroxybenzaldehyde-d4 is the deuterium labeled p-Hydroxybenzaldehyde p-Hydroxybenzaldehyde is a one of the major components in Dendrocalamus asper bamboo shoots with antagonistic effect on GABAA receptor of the 1 2 2S subtype at high concentrations
Medchemexpress LLC o,p'-DDE (2,4'-DDE) | 3424-82-6 | >=95.0% | 50 MG
o,p'-DDE (2,4'-DDE) is an organochlorine pesticide metabolite and degradation product of DDT commonly used as an analytical standard and in toxicological and environmental research.
- Metabolite of DDT commonly used as an analytical standard
- CAS number 3424-82-6
- Molecular formula C14H8Cl4, molecular weight 318.03 g/mol
- Provided as a small solid package suitable for laboratory use
- Purity not specified on product page; check Certificate of Analysis for lot-specific purity
TARGETMOL CHEMICALS INC LRRK2-IN-1 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. LRRK2-IN-1 is an effective and selective LRRK2 inhibitor. purity: 98%
eMolecules 2-Bromo-4-methylphenol | Combi-Blocks | 6627-55-0 | MFCD00002151 | 187.036 | C7H7BrO | 98.000 | Cc1ccc(O)c(Br)c1 | 100g | 232308089
2-Bromo-4-methylphenol | Combi-Blocks | 6627-55-0 | MFCD00002151 | 187.036 | C7H7BrO | 98.000 | Cc1ccc(O)c(Br)c1 | 100g | 232308089
Cambridge Isotope Laboratories 1 2 3 4 7 8-Hexabromodibenzo-p-dioxin (13C12 99%) 5 ug/mL in nonane toluene (70 30) 1 2 mL
1 2 3 4 7 8-Hexabromodibenzo-p-dioxin (13C12 99%) 5 ug/mL in nonane toluene (70 30) 1 2 mL
Cambridge Isotope Laboratories 1 2 3 4 6 7 8-Heptabromodibenzo-p-dioxin (13C12 99%) 5 ug/mL in nonane toluene (70 30) 4 x 1 2 mL
1 2 3 4 6 7 8-Heptabromodibenzo-p-dioxin (13C12 99%) 5 ug/mL in nonane toluene (70 30) 4 x 1 2 mL
Cambridge Isotope Laboratories 1 2 3 7 8-Pentabromodibenzo-p-dioxin (unlabeled) 5 ug/mL in nonane 8 x 1 2 mL
1 2 3 7 8-Pentabromodibenzo-p-dioxin (unlabeled) 5 ug/mL in nonane 8 x 1 2 mL
Medchemexpress LLC Pomalidomide-amido-PEG3-C2-NH2 | 2328070-52-4 | 99.5% | 100 MG
Pomalidomide-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate designed for use in PROTAC technology. It incorporates a Pomalidomide-based cereblon ligand and a 3-unit PEG linker. This compound is for research use only and can be used to synthesize BI-3663, which degrades focal adhesion tyrosine kinase (PTK2).
- Synthesized E3 ligase ligand-linker conjugate
- Incorporates pomalidomide-based cereblon ligand
- Features a 3-unit PEG linker
- Used in PROTAC technology
- Can be used to synthesize BI-3663
- Applicable in degrading PTK2 in hepatocellular carcinoma cell lines